Neoleukin Therapeutics Email Format

Biotechnology ResearchWashington, United States51-200 Employees

Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We historically created next generation immunotherapies using breakthrough de novo protein design technology. 

In December 2023, the previously announced merger between Neurogene Inc and Neoleukin Therapeutics (NGNE) was completed. Neurogene is a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases.

For more information about the Neurogene, please visit www.neurogene.com, @NeurogeneInc on X (formerly Twitter) or @Neurogene Inc on LinkedIn.

✕

Access Insights for Neoleukin Therapeutics and Millions of Other Companies

Sign up for full access to Neoleukin Therapeutics information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory